Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Notch Signaling Regulates T Cell Accumulation and Function in the Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Neuroinflammation: The role and consequences.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study.
Environmental factors and their regulation of immunity in multiple sclerosis.
Spasticity in multiple sclerosis: results of a patient survey.
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.
Isolation & characterization of Bartonella sp. from optic neuritis patients.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Purkinje cell fusion and binucleate heterokaryon formation in multiple sclerosis cerebellum.
Chiasmal optic neuritis in a 4-year-old girl: a case report and review of the literature.
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
The potential of microRNAs as biofluid markers of neurodegenerative diseases - a systematic review.
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.
Association of smoking with risk of multiple sclerosis: a population-based study.
A Model of Population and Subject (MOPS) Intensities with Application to Multiple Sclerosis Lesion Segmentation.
Increased perfusion in normal appearing white matter in high inflammatory multiple sclerosis patients.
Pages
« first
‹ previous
…
271
272
273
274
275
276
277
278
279
…
next ›
last »